Skip Nav Destination
Genomics in myeloma: the philosopher's stone?
Karyng about karyotyping in adult ALL
Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
T−B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3ζ subunit of the T-cell antigen receptor complex
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis
Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia
Vitamin K–containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia
MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation
Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications
Issue Archive
April 15 2007
In this Issue
Table of Contents
INSIDE BLOOD
CLINICAL TRIALS AND OBSERVATIONS
Genomics in myeloma: the philosopher's stone?
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Karyng about karyotyping in adult ALL
Clinical Trials & Observations
PLENARY PAPERS
PERSPECTIVE
Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions
Clinical Trials & Observations
REVIEW ARTICLES
REVIEW IN TRANSLATIONAL HEMATOLOGY
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
Clinical Trials & Observations
George Mulligan,Constantine Mitsiades,Barb Bryant,Fenghuang Zhan,Wee J. Chng,Steven Roels,Erik Koenig,Andrew Fergus,Yongsheng Huang,Paul Richardson,William L. Trepicchio,Annemiek Broyl,Pieter Sonneveld,John D. Shaughnessy, Jr,P. Leif Bergsagel,David Schenkein,Dixie-Lee Esseltine,Anthony Boral,Kenneth C. Anderson
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Clinical Trials & Observations
Anthony V. Moorman,Christine J. Harrison,Georgina A. N. Buck,Sue M. Richards,Lorna M. Secker-Walker,Mary Martineau,Gail H. Vance,Athena M. Cherry,Rodney R. Higgins,Adele K. Fielding,Letizia Foroni,Elisabeth Paietta,Martin S. Tallman,Mark R. Litzow,Peter H. Wiernik,Jacob M. Rowe,Anthony H. Goldstone,Gordon W. Dewald,on behalf of the Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Adult Leukaemia Working Party of the United Kingdom and the Eastern Cooperative Oncology Group
T−B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3ζ subunit of the T-cell antigen receptor complex
Clinical Trials & Observations
Joseph L. Roberts,Jens Peter H. Lauritsen,Myriah Cooney,Roberta E. Parrott,Elisa O. Sajaroff,Chan M. Win,Michael D. Keller,Jeffery H. Carpenter,Juan Carabana,Michael S. Krangel,Marcella Sarzotti,Xiao-Ping Zhong,David L. Wiest,Rebecca H. Buckley
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis
Clinical Trials & Observations
Jorge Cortes,Philippe Rousselot,Dong-Wook Kim,Ellen Ritchie,Nelson Hamerschlak,Steven Coutre,Andreas Hochhaus,Francois Guilhot,Giuseppe Saglio,Jane Apperley,Oliver Ottmann,Neil Shah,Philipp Erben,Susan Branford,Prasheen Agarwal,Ashwin Gollerkeri,Michele Baccarani
Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia
Clinical Trials & Observations
Elias Jabbour,Susan O'Brien,Hagop Kantarjian,Guillermo Garcia-Manero,Alessandra Ferrajoli,Farhad Ravandi,Maria Cabanillas,Deborah A. Thomas
HEMATOPOIESIS
ERRATUM
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins
Iain C. Macaulay,Marloes R. Tijssen,Daphne C. Thijssen-Timmer,Arief Gusnanto,Michael Steward,Philippa Burns,Cordelia F. Langford,Peter D. Ellis,Frank Dudbridge,Jaap-Jan Zwaginga,Nicholas A. Watkins,C. Ellen van der Schoot,Willem H. Ouwehand
Vitamin K–containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7
Clinical Trials & Observations
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation
Clinical Trials & Observations
Brief Report
Venée N. Tubman,Jason E. Levine,Dean R. Campagna,Rita Monahan-Earley,Ann M. Dvorak,Ellis J. Neufeld,Mark D. Fleming
IMMUNOBIOLOGY
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
Hiroyuki Kishimoto,Toshiaki Ohteki,Nobuyuki Yajima,Koichi Kawahara,Miyuki Natsui,Satoru Kawarasaki,Koichi Hamada,Yasuo Horie,Yoshiaki Kubo,Seiji Arase,Masaru Taniguchi,Bart Vanhaesebroeck,Tak Wah Mak,Toru Nakano,Shigeo Koyasu,Takehiko Sasaki,Akira Suzuki
NEOPLASIA
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia
Deepa B. Shankar,Junling Li,Paul Tapang,J. Owen McCall,Lori J. Pease,Yujia Dai,Ru-Qi Wei,Daniel H. Albert,Jennifer J. Bouska,Donald J. Osterling,Jun Guo,Patrick A. Marcotte,Eric F. Johnson,Niru Soni,Kresna Hartandi,Michael R. Michaelides,Steven K. Davidsen,Saul J. Priceman,Jenny C. Chang,Katrin Rhodes,Neil Shah,Theodore B. Moore,Kathleen M. Sakamoto,Keith B. Glaser
Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo
Guang-Biao Zhou,Hui Kang,Lan Wang,Li Gao,Ping Liu,Jun Xie,Feng-Xiang Zhang,Xiang-Qin Weng,Zhi-Xiang Shen,Jue Chen,Long-Jun Gu,Ming Yan,Dong-Er Zhang,Sai-Juan Chen,Zhen-Yi Wang,Zhu Chen
Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
Takashi Akasaka,Theodore Balasas,Lisa J. Russell,Kei-ji Sugimoto,Aneela Majid,Renata Walewska,E. Loraine Karran,David G. Brown,Kelvin Cain,Lana Harder,Stefan Gesk,Jose Ignacio Martin-Subero,Mark G. Atherton,Monika Brüggemann,María José Calasanz,Teresa Davies,Oskar A. Haas,Anne Hagemeijer,Helena Kempski,Michel Lessard,Debra M. Lillington,Sarah Moore,Florence Nguyen-Khac,Isabelle Radford-Weiss,Claudia Schoch,Stéphanie Struski,Polly Talley,Melanie J. Welham,Helen Worley,Jon C. Strefford,Christine J. Harrison,Reiner Siebert,Martin J. S. Dyer
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
Clinical Trials & Observations
Sophia S. Wang,Susan L. Slager,Paul Brennan,Elizabeth A. Holly,Silvia De Sanjose,Leslie Bernstein,Paolo Boffetta,James R. Cerhan,Marc Maynadie,John J. Spinelli,Brian C. H. Chiu,Pier Luigi Cocco,Fiona Mensah,Yawei Zhang,Alexandra Nieters,Luigino Dal Maso,Paige M. Bracci,Adele Seniori Costantini,Paolo Vineis,Richard K. Severson,Eve Roman,Wendy Cozen,Dennis Weisenburger,Scott Davis,Silvia Franceschi,Carlo La Vecchia,Lenka Foretova,Nikolaus Becker,Anthony Staines,Martine Vornanen,Tongzhang Zheng,Patricia Hartge
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome
Clinical Trials & Observations
Hervé Avet-Loiseau,Michel Attal,Philippe Moreau,Catherine Charbonnel,Frédéric Garban,Cyrille Hulin,Serge Leyvraz,Mauricette Michallet,Ibrahim Yakoub-Agha,Laurent Garderet,Gérald Marit,Lucienne Michaux,Laurent Voillat,Marc Renaud,Bernard Grosbois,Gaelle Guillerm,Lotfi Benboubker,Mathieu Monconduit,Catherine Thieblemont,Philippe Casassus,Denis Caillot,Anne-Marie Stoppa,Jean-Jacques Sotto,Marc Wetterwald,Charles Dumontet,Jean-Gabriel Fuzibet,Isabelle Azais,Véronique Dorvaux,Marc Zandecki,Régis Bataille,Stéphane Minvielle,Jean-Luc Harousseau,Thierry Facon,Claire Mathiot
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia
Clinical Trials & Observations
Brief Report
Stephane Picard,Karine Titier,Gabriel Etienne,Emmanuelle Teilhet,Dominique Ducint,Marie-Agnes Bernard,Regis Lassalle,Gerald Marit,Josy Reiffers,Bernard Begaud,Nicholas Moore,Mathieu Molimard,Francois-Xavier Mahon
MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation
Brief Report
Alexander J. A. Deutsch,Ariane Aigelsreiter,Philipp B. Staber,Alfred Beham,Werner Linkesch,Christian Guelly,Ruth I. Brezinschek,Margareta Fruhwirth,Werner Emberger,Maike Buettner,Christine Beham-Schmid,Peter Neumeister
PHAGOCYTES
RED CELLS
Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell α4β1integrin: role in adhesion of sickle red blood cells to endothelial cells
Wassim El Nemer,Marie-Paule Wautier,Cécile Rahuel,Pierre Gane,Patricia Hermand,Frédéric Galactéros,Jean-Luc Wautier,Jean-Pierre Cartron,Yves Colin,Caroline Le Van Kim
STEM CELLS IN HEMATOLOGY
TRANSPLANTATION
Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
Clinical Trials & Observations
Charles Crawley,Simona Iacobelli,Bo Björkstrand,Jane F. Apperley,Dietger Niederwieser,Gösta Gahrton,for the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications
Clinical Trials & Observations
Manfred Hönig,Michael H. Albert,Ansgar Schulz,Monika Sparber-Sauer,Catharina Schütz,Bernd Belohradsky,Tayfun Güngör,Markus T. Rojewski,Harald Bode,Ulrich Pannicke,Dominique Lippold,Klaus Schwarz,Klaus-Michael Debatin,Michael S. Hershfield,Wilhelm Friedrich
CORRESPONDENCE
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals